Listen to Gynecologic Oncology
Today: #142 in Science, South Africa on our combined chart.
Chart positions today · India
Not on the United States charts we track today.
Not on the United Kingdom charts we track today.
Not on the Canada charts we track today.
Not on the Australia charts we track today.
Not on the Germany charts we track today.
Not on the Brazil charts we track today.
Not on the Mexico charts we track today.
Not on the New Zealand charts we track today.
Not on the Ireland charts we track today.
Not on the India charts we track today.
Not on the Japan charts we track today.
Not on the Philippines charts we track today.
If you like Listen to Gynecologic Oncology, try…
Ranking history · India
Latest episodes
-
Do We Have the Courage? Pregnancy, Policy, and the Price Surgeons Pay
September 28, 2026 · 42 minEditor's Choice: Pregnancies in gynecologic oncologists: An assessment of pregnancy policies and complications within a surgical subspecialty Editorial: Pregnancy complications in gynecologic oncologists – A call to action to do…
-
FIGO 2023 Upstaging: Overtreatment or Overdue Precision?
September 1, 2026 · 32 minEditor's Choice: FIGO 2023 staging may result in overtreatment of early-stage endometrial cancer Editorial: A path to precision in endometrial cancer management: Moving past FIGO 2023 Hosted by: David Gaffney, MD, PhD The University of…
-
ERAS 2026: Key Updates Every Gynecologic Oncologist Should Know
July 31, 2026 · 27 minEditor's Choice: Enhanced recovery after surgery (ERAS®) society guidelines for gynecologic oncology: 2026 update Editorial: The evolving landscape of personalized perioperative care: A commentary on the 2026 ERAS® Gynecologic oncology…
-
Beyond the Binary: Unpacking Molecular Diversity in PMMR Endometrial Cancer
July 29, 2026 · 26 minEditor's Choice: Biomarker heterogeneity and efficacy of durvalumab plus carboplatin/paclitaxel followed by durvalumab with or without olaparib in patients with mismatch repair proficient endometrial cancer: exploratory analyses of the…
-
Cologuard-like test for identification of endometrial cancer through vaginal sampling
May 13, 2026 · 26 minEditor's Choice: Optimization of methylated DNA markers to rule out endometrial cancer in patients with abnormal uterine bleeding Editorial: Tampon-based methylated DNA testing for endometrial cancer: Promising innovation, but prudence…
Show 7 more episodesShow fewer episodes
-
PARP Inhibitors in Ovarian Cancer: A Society of Gynecologic Oncology Podcast
May 8, 2026 · 20 minUpdates in US Food and Drug Administration approvals for poly-ADP-ribose polymerase inhibitors in Ovarian Cancer: A society of gynecologic oncology clinical practice review Moderator: Ursula A. Matulonis, MD; Dana-Farber Cancer…
-
Home the Same Day? Testing the Limits in Ovarian Cancer Debulking Surgery
April 9, 2026 · 18 minEditor's Choice: Same day discharge after minimally invasive interval debulking surgery in advanced stage ovarian cancer Editorial: Same-day discharge in advanced ovarian cancer as a milestone of surgical evolution and patient…
-
Recognizing and Managing ADC-Associated Pulmonary Toxicities
March 16, 2026 · 30 minEditor’s Choice: Interstitial lung disease in targeted therapies: A Society of Gynecologic Oncology clinical practice statement Hosted by: Jose Alejandro Rauh-Hain, MD MPH Department of Gynecologic Oncology and Reproductive Medicine, The…
-
In good SHAPE
February 1, 2026 · 24 minEditor's Choice: Comparative outcomes of simple versus radical hysterectomy in patients with and without very low-risk early-stage cervical cancer: An exploratory analysis from the Gynecologic Cancer Intergroup/Canadian Cancer Trials…
-
ctDNA-Guided PARPi Therapy in Ovarian Cancer
January 1, 2026 · 25 minEditor’s Choice: Circulating tumor DNA monitoring in ovarian cancer patients receiving PARPi maintenance therapy: Can we further personalize treatment? Editorial: Towards personalizing PARP inhibitor maintenance therapy for ovarian…
-
Beyond treatment: The who, why, when, where and what of cancer follow up
December 1, 2025 · 28 minEditor’s Choice: Reconsidering follow-up care in gynaecologic oncology: A scoping review exploring alternative approaches Editorial: Who is following up? Rethinking survivorship and surveillance Hosted by: Paola A Gehrig, MD University of…
-
Ovarian Cancer After Breast Cancer in Women with BRCA Variants
November 20, 2025 · 29 minEditor’s Choice: Ovarian cancer after breast cancer in women with a BRCA1 or BRCA2 pathogenic variant Editorial: Does a diagnosis of breast cancer reduce ovarian cancer risk in BRCA1/2 carriers:Why is this a question? Hosted by: John…